Trade Talis Biomedical Corporation - TLIS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 4.13 |
| Open | 4.15 |
| 1-Year Change | -33.28% |
| Day's Range | 3.95 - 4.38 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Aug 30, 2024 | 4.36 | 0.21 | 5.06% | 4.15 | 4.38 | 3.94 |
| Aug 29, 2024 | 4.13 | 0.06 | 1.47% | 4.07 | 4.38 | 4.06 |
| Aug 28, 2024 | 3.98 | 0.20 | 5.29% | 3.78 | 3.98 | 3.78 |
| Aug 27, 2024 | 3.83 | -0.09 | -2.30% | 3.92 | 3.92 | 3.72 |
| Aug 26, 2024 | 3.98 | 0.30 | 8.15% | 3.68 | 3.98 | 3.60 |
| Aug 23, 2024 | 4.36 | 0.32 | 7.92% | 4.04 | 4.38 | 4.04 |
| Aug 22, 2024 | 4.15 | -0.14 | -3.26% | 4.29 | 4.55 | 4.15 |
| Aug 21, 2024 | 4.26 | 0.13 | 3.15% | 4.13 | 4.33 | 4.13 |
| Aug 20, 2024 | 4.07 | 0.01 | 0.25% | 4.06 | 4.29 | 4.03 |
| Aug 19, 2024 | 4.39 | 0.00 | 0.00% | 4.39 | 4.43 | 4.28 |
| Aug 16, 2024 | 4.33 | 0.44 | 11.31% | 3.89 | 4.33 | 3.89 |
| Aug 15, 2024 | 4.07 | -0.01 | -0.25% | 4.08 | 4.13 | 3.99 |
| Aug 14, 2024 | 3.99 | 0.02 | 0.50% | 3.97 | 4.13 | 3.78 |
| Aug 13, 2024 | 4.03 | 0.19 | 4.95% | 3.84 | 4.03 | 3.84 |
| Aug 12, 2024 | 3.89 | 0.14 | 3.73% | 3.75 | 4.03 | 3.75 |
| Aug 9, 2024 | 3.73 | -0.22 | -5.57% | 3.95 | 4.25 | 3.70 |
| Aug 8, 2024 | 4.18 | -0.20 | -4.57% | 4.38 | 4.39 | 3.95 |
| Aug 7, 2024 | 4.53 | 0.05 | 1.12% | 4.48 | 4.94 | 4.10 |
| Aug 6, 2024 | 8.97 | 0.17 | 1.93% | 8.80 | 9.03 | 8.48 |
| Aug 5, 2024 | 8.68 | 0.15 | 1.76% | 8.53 | 8.97 | 8.38 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Talis Biomedical Corporation Company profile
About Talis Biomedical Corp
Talis Biomedical Corporation. (Talis) Is engaged in developing molecular diagnostic tests for infectious diseases at the point of care. The Company is focused on developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions. Talis is developing the Talis One platform, a cloud-enabled molecular diagnostic platform. The Talis One platform comprises a compact instrument, single-use test cartridges and software, including a central cloud database, which work together and are designed to provide central laboratory levels of accuracy. The platform is designed for use in non-laboratory settings, such as physicians’ offices, hospital emergency departments, urgent care clinics, ambulatory surgery centers, assisted living facilities, and cancer treatment and dialysis centers. The Company is also developing Talis One tests for respiratory infections, infections related to women’s health and sexually transmitted infections.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Talis Biomedical Corp revenues decreased 25% to $8.2M. Net loss increased from $91.1M to $192M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Basic Earnings per Share excluding Extraordinary Items decreased from -$3.88 to -$7.30.
| Industry: | Biotechnology & Medical Research (NEC) |
1100 Island Drive
Suite 101
REDWOOD CITY
CALIFORNIA 94065
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com